Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimigraine drugs.

H C Diener1, H Kaube, V Limmroth

  • 1Department of Neurology, University of Essen, Germany. h.diener@uni-essen.de

Journal of Neurology
|August 27, 1999
PubMed
Summary
This summary is machine-generated.

New migraine treatments offer improved acute attack management and prophylaxis. Options range from antiemetics and analgesics to serotonin agonists and novel prophylactic agents like valproic acid.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Placebo Response in Acute and Prophylactic Treatment of Migraine: A Systematic Review and Meta-Analysis Covering 36 Years of Research.

Neurologic clinics·2025
Same author

[Diagnosis and treatment of acute ischemic insults].

Herz·2021
Same author

European Academy of Neurology guideline on the management of medication-overuse headache.

European journal of neurology·2020
Same author

MMW Fortschritte der Medizin·2018
Same author

Preventing dementia beyond treating hypertension.

European heart journal·2018
Same author

MMW Fortschritte der Medizin·2018

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraine is a neurological disorder causing severe headaches and associated symptoms.
  • Acute attacks and prophylaxis require effective therapeutic strategies.

Purpose of the Study:

  • To review emerging treatment options for acute migraine attacks.
  • To summarize new pharmacological agents for migraine prophylaxis.

Main Methods:

  • Literature review of recent studies on migraine therapeutics.
  • Analysis of new drug classes including triptans and prophylactic medications.

Main Results:

  • Mild to moderate migraines managed with antiemetics, analgesics, or ergotamines.
  • Serotonin (5-HT)1B/D agonists (triptans) are effective for resistant cases.

Related Experiment Videos

  • New triptans (zolmitriptan, naratriptan, rizatriptan, eletriptan) show nuanced efficacy and side effect profiles.
  • Novel prophylactic agents include cyclandelate, valproic acid, and magnesium.

    • Conclusions:

    • Several new pharmacological options enhance acute migraine attack treatment.
    • Emerging drugs provide additional choices for migraine prophylaxis.